Details of the Drug

General Information of Drug (ID: DMXYHC7)

Drug Name
RU-101
Synonyms RU-10; Recombinant human serum albumin (ocular, dry eye), R-Tech Ueno
Indication
Disease Entry ICD 11 Status REF
Xerophthalmia 5B55.Y Phase 1/2 [1]
Cross-matching ID
TTD ID
D0YW6P

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Serum albumin (ALB) TTFNGC9 ALBU_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Xerophthalmia
ICD Disease Classification 5B55.Y
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Serum albumin (ALB) DTT ALB 7.92E-01 -0.07 -0.44
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01843894) A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye. U.S. National Institutes of Health.
2 Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol. 2003 October; 87(10): 1279-1283.